The University of Chicago Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Nishant Agrawal and Zhen Gooi.
Nishant Agrawal
Connection Strength
2.433
Zhen Gooi
  1. Tonsil Cancer. N Engl J Med. 2019 Jul 25; 381(4):e8.
    View in: PubMed
    Score: 0.739
  2. Lip and Oral Cavity Squamous Cell Carcinoma. Hematol Oncol Clin North Am. 2021 10; 35(5):895-911.
    View in: PubMed
    Score: 0.212
  3. Head and Neck Masses. Med Clin North Am. 2018 Nov; 102(6):1013-1025.
    View in: PubMed
    Score: 0.174
  4. Role of dental hardware in oral cavity squamous cell carcinoma in the low-risk nonsmoker nondrinker population. Head Neck. 2018 04; 40(4):784-792.
    View in: PubMed
    Score: 0.167
  5. AHNS Series - Do you know your guidelines? Principles of treatment for glottic cancer: A review of the National Comprehensive Cancer Network guidelines. Head Neck. 2017 09; 39(9):1729-1732.
    View in: PubMed
    Score: 0.160
  6. Risk of thyroid malignancy following an index head and neck squamous cell carcinoma: A population-based study. Ear Nose Throat J. 2016 Dec; 95(12):E7-E11.
    View in: PubMed
    Score: 0.154
  7. AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines. Head Neck. 2017 02; 39(2):201-205.
    View in: PubMed
    Score: 0.154
  8. Risk of second primary malignancy after nasopharyngeal carcinoma in the United States: A population-based study. Head Neck. 2016 04; 38 Suppl 1:E1130-6.
    View in: PubMed
    Score: 0.141
  9. Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke. Head Neck. 2015 Nov; 37(11):1642-9.
    View in: PubMed
    Score: 0.131
  10. Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma. Br J Cancer. 2022 11; 127(8):1497-1506.
    View in: PubMed
    Score: 0.057
  11. Characterizing Lymph Node Burden With Elective Unilateral Neck Irradiation in Human Papillomavirus-Positive Tonsil Squamous Cell Carcinoma: Defining the Upper Limits. Cureus. 2022 Jul; 14(7):e27521.
    View in: PubMed
    Score: 0.057
  12. Molecular drivers of oral cavity squamous cell carcinoma in non-smoking and non-drinking patients: what do we know so far? Oncol Rev. 2022 Feb 22; 16(1):549.
    View in: PubMed
    Score: 0.055
  13. Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment. BMC Cancer. 2022 Jan 03; 22(1):17.
    View in: PubMed
    Score: 0.055
  14. Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience. Oral Oncol. 2021 11; 122:105566.
    View in: PubMed
    Score: 0.054
  15. Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes. Int J Radiat Oncol Biol Phys. 2020 07 15; 107(4):662-671.
    View in: PubMed
    Score: 0.049
  16. Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience. Oral Oncol. 2018 05; 80:16-22.
    View in: PubMed
    Score: 0.042
  17. Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay. Oral Oncol. 2014 Jun; 50(6):600-4.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.